CClinicalTrials.gg
Not yet recruitingNCT07501871DMU-CHUpdated Apr 21, 2026

Investigation of Digital Media Use in Patients Receiving Chemotherapy

An observational study in Cancer and Chemotherapy, sponsored by Fenerbahce University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 67 Years. Per ClinicalTrials.gov, last updated 2026-04-21.

Sponsored by Fenerbahce University · Observational

From the registry’s dates

  • Primary completion was expected by May 2026, 4 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
80
Ages
18 Years to 67 Years
Sex
All
01

Study summary

This study aims to examine digital media use and eHealth literacy among patients receiving chemotherapy. Digital media has become an important tool for accessing health information, communicating with healthcare providers, and supporting self-management.

This observational study will be conducted with adult patients receiving chemotherapy in an outpatient setting. Data will be collected using a sociodemographic information form and the eHealth Literacy Scale (eHEALS). The findings are expected to contribute to a better understanding of digital media use and digital health literacy levels in chemotherapy patients.

Read the detailed description

Cancer is a major global health problem, and chemotherapy is one of the most commonly used treatment methods. With the increasing use of digital media, patients frequently access health-related information, communicate with healthcare providers, and engage in self-management. Digital health literacy plays a key role in this process.

This study aims to describe digital media use and eHealth literacy levels among patients receiving chemotherapy. It will also explore the relationship between digital media use and selected patient characteristics.

The study will be conducted as a descriptive, cross-sectional observational study in an outpatient chemotherapy setting. Data will be collected using a sociodemographic information form and the eHealth Literacy Scale (eHEALS).

02

Conditions studied

  • Cancer
  • Chemotherapy

Browse trials for

Keywords

  • Oncology Nursing
  • Digital Media
  • eHealth Literacy
03

In context

Neoplasms

9,365 studies on the registry are indexed under Neoplasms; 2,489 are open to participants now.

This study's planned enrollment of 80 is below the median of 204 across 1,683 observational studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

Fenerbahce University is the lead sponsor of 73 studies on the registry; 44 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 67 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients aged between 18 and 67 years receiving chemotherapy treatment in an outpatient setting will be included in the study. Participants will be selected according to the inclusion and exclusion criteria and will voluntarily agree to participate.

Inclusion criteria

  • Patients aged between 18 and 67 years
  • Receiving chemotherapy treatment
  • Able to communicate and understand the study procedures
  • Voluntarily agree to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Patients with cognitive impairment or communication difficulties
  • Patients who refuse to participate
  • Patients with incomplete questionnaire responses
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
80 participants (estimated)
Patient registry
No

Groups and cohorts

  • Chemotherapy Patients

    Patients receiving chemotherapy whose digital media use and eHealth literacy are assessed.

    Other: No Intervention (Observational Study)

Interventions

  • OtherNo Intervention (Observational Study)

    This is an observational study with no assigned intervention. Data will be collected through surveys assessing digital media use and eHealth literacy.

06

What researchers measure

Primary outcomes

  1. Digital Media Use Level

    Digital media use will be evaluated based on frequency, duration, and purpose of use through a structured questionnaire.

    Time frame: At baseline (during chemotherapy treatment)

Secondary outcomes

  1. eHealth Literacy Level

    eHealth literacy will be assessed using the eHealth Literac Scale (eHEALS)

    Time frame: At baseline

Other outcomes

  1. Relationship Between Digital Media Use and eHealth Literacy

    The association between digital media use and eHealth literacy will be analyzed using statistical methods.

    Time frame: At baseline

07

Study locations

1 site
  • Acıbadem University Atakent Hospital
    Istanbul, Küçükçekmece, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07501871
Lead sponsor
Fenerbahce University
Responsible party
Emine I Yıldız (Nurse, Fenerbahce University) — Principal investigator
First posted
Mar 30, 2026
Start date
Apr 20, 2026 (estimated)
Primary completion
May 20, 2026 (estimated)
Completion
May 20, 2026 (estimated)
Last update
Apr 21, 2026

Study contacts

Emine Ilayda Yildiz, RN
Contact
emineeilaydaa@gmail.com
+905436411944
Emine Ilayda Yildiz
principal investigator · Fenerbahce University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion